XML 32 R20.htm IDEA: XBRL DOCUMENT v3.24.2
Income Per Share and Stockholders' Equity
 6 Months Ended
Jun. 30, 2024
Earnings Per Share And Stockholders Equity [Abstract]  
Income Per Share and Stockholders' Equity Income Per Share and Stockholders’ Equity
The calculations of basic and diluted income per share attributable to CBRE Group, Inc. stockholders are as follows (dollars in millions, except share and per share data):
Three Months Ended
June 30,		Six Months Ended
June 30,
2024202320242023
Basic Income Per Share
Net income attributable to CBRE Group, Inc. stockholders$130 $201 $256 $318 
Weighted average shares outstanding for basic income per share306,745,116 310,857,203 306,276,871 310,662,324 
Basic income per share attributable to CBRE Group, Inc. stockholders$0.42 $0.65 $0.84 $1.02 
Diluted Income Per Share
Net income attributable to CBRE Group, Inc. stockholders$130 $201 $256 $318 
Weighted average shares outstanding for basic income per share306,745,116 310,857,203 306,276,871 310,662,324 
Dilutive effect of contingently issuable shares1,290,095 3,425,044 1,992,169 4,159,291 
Weighted average shares outstanding for diluted income per share308,035,211 314,282,247 308,269,040 314,821,615 
Diluted income per share attributable to CBRE Group, Inc. stockholders$0.42 $0.64 $0.83 $1.01 
For the three and six months ended June 30, 2024, 983,949 and 693,772, respectively, of contingently issuable shares were excluded from the computation of diluted income per share because their inclusion would have had an anti-dilutive effect.
For the three and six months ended June 30, 2023, 1,433,176 and 988,371, respectively, of contingently issuable shares were excluded from the computation of diluted income per share because their inclusion would have had an anti-dilutive effect.
On November 19, 2021, our board of directors authorized a program for the repurchase of up to $2.0 billion of our Class A common stock over five years (the 2021 program). On August 18, 2022, our board of directors authorized an additional $2.0 billion, bringing the total authorized repurchase amount under this program to a total of $4.0 billion. We did not repurchase any of our common stock during the three months ended March 31, 2024 under the 2021 program. During the three months ended June 30, 2024, we repurchased 554,741 shares of our common stock with an average price of $87.25 per share using cash on hand for an aggregate of $48.4 million under the 2021 program. As of June 30, 2024, we had approximately $1.4 billion of capacity remaining under the 2021 program. During the three months ended March 31, 2023, we repurchased 1,368,173 shares of our common stock using cash on hand for an aggregate of $114.2 million. We did not repurchase any of our common stock during the three months ended June 30, 2023 under the 2021 program.